Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
…tients with brain metastases treated with ALK TKIs (brigatinib, crizotinib) were analyzed. Radiomic features were extracted from baseline …
… IP PTX efficacy.Conclusions These results demonstrated that IP paclitaxel reprograms peritoneal macrophages and DCs toward pro-inflammato…
…e. 16 patients with stage III/IV unresectable melanoma received Pembrolizumab and, 12 weeks later, treatment with six initial EVX-01 priming …
….5 months), all of whom received platinum-based chemotherapy (± bevacizumab) in first- or second-line settings; 86 patients also received c…
…paraffin embedding (FF and FFPE), rehydrated, labeled (ST6Gal1+ CMP-Neu5Biotin+Strep-Alexafluor), and analyzed by flow cytometry. For tissue-l…
…prising 10-15% of breast cancers. Immune checkpoint inhibitors (ICIs), especially when combined with radiation therapy (RT), have sh…
…rest in combining EZH2 inhibitors with adoptive cell therapies. Tazemetostat, a potent EZH2 inhibitor, is FDA-approved for epithelioid sarco…
…audin-3 (CLDN3) antibody for PTT and applied a fusion cytokine (ABN202), consisting of IFN-β linked to the same antibody, to further p…
…to assess the safety and efficacy of the multikinase inhibitor, sorafenib, combined with ICI nivolumab (anti-PD-1), in 16 patients with H…
…lliam NW Jr, Weissferdt A, et al. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung canc…
…ed. 2018;378:1479–1493.Cappellini MD, et al. A phase 3 trial of luspatercept in patients with transfusiondependent β- thalassemia. N. Engl. …
…4.42.16_suppl.70472 U.S. FDA approves Bristol Myers Squibb’s 2. Breyanzi® as the first and only CAR T-cell therapy for adults with relap…